Express News | Zhejiang Jianfeng Group: Subsidiary Jianfeng Pharmaceutical's Rosuvastatin capsules have obtained the Pharmaceutical registration certificate.

BreakingsMar 10 16:15

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 3 10:09

Zhejiang Jianfeng Group Unit Secures Approval for API Market Entry

MT NewswiresFeb 21 18:38

Zhejiang Jianfeng Group (600668.SH): Subsidiary has received the approval notice for the listing application of Chemical Raw Materials.

On February 20, Gelonghui reported that Zhejiang Jianfeng Group (600668.SH) announced that its wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical") received the "Approval Notice for the Listing Application of Chemical Raw Materials for Rosuvastatin" from the National Medical Products Administration (Notice No.: 2025YS00138). This approval indicates that the Active Pharmaceutical Ingredient has met the national technical standards for the review of related raw materials and can be sold in the domestic market, which will help expand the business scope of the subsidiary.

Gelonghui FinanceFeb 20 15:46

Express News | Zhejiang Jianfeng Group: The cable company has entered the Nuclear Power Communications field, and the first batch of cables has been successfully delivered.

BreakingsFeb 17 13:56

Zhejiang Jianfeng Group (600668.SH): The Shareholder's equity structure of the controlling shareholder has changed.

On January 21, Gelonghui reported that Zhejiang Jianfeng Group (600668.SH) announced that it recently received a notification from the Jinhua Municipal State-owned Assets Supervision and Administration Commission regarding the equity transfer of the company's largest Shareholder, Jinhua Tongji State-owned Assets Investment Co., Ltd. (referred to as "Tongji Investment"). There will be a change in Shareholders of Tongji Investment. According to the document from the Jinhua Municipal Government State-owned Assets Supervision and Administration Commission entitled "Notification Regarding the Equity Transfer of Jinhua Tongji State-owned Assets Investment Co., Ltd.", the Jinhua Municipal State-owned Assets Supervision and Administration Commission has decided to transfer 100% equity of Tongji Investment held by Jinhua State Capital Operation Co., Ltd. (referred to as "State-owned Assets Company").

Gelonghui FinanceJan 21 15:58